Bayer’s BlueRock Therapeutics establishes European website for cell remedy innovation
Berlin, June 8, 2022 - Bayer AG announced today that BlueRock Therapeutics LP (BlueRock), a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, has established a new site for cell therapy innovation on…